nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP2D6—Gefitinib—lung cancer	0.0598	0.108	CbGbCtD
Palonosetron—CYP2D6—Vinorelbine—lung cancer	0.0461	0.0832	CbGbCtD
Palonosetron—CYP1A2—Erlotinib—lung cancer	0.0429	0.0775	CbGbCtD
Palonosetron—CYP3A4—Topotecan—lung cancer	0.0416	0.0751	CbGbCtD
Palonosetron—CYP3A4—Gefitinib—lung cancer	0.0381	0.0687	CbGbCtD
Palonosetron—CYP3A4—Teniposide—lung cancer	0.0369	0.0666	CbGbCtD
Palonosetron—CYP2D6—Erlotinib—lung cancer	0.0354	0.0639	CbGbCtD
Palonosetron—CYP1A2—Etoposide—lung cancer	0.0311	0.0561	CbGbCtD
Palonosetron—CYP3A4—Vinorelbine—lung cancer	0.0293	0.0529	CbGbCtD
Palonosetron—CYP2D6—Vinblastine—lung cancer	0.0284	0.0513	CbGbCtD
Palonosetron—CYP3A4—Crizotinib—lung cancer	0.0233	0.0421	CbGbCtD
Palonosetron—CYP3A4—Erlotinib—lung cancer	0.0225	0.0406	CbGbCtD
Palonosetron—CYP3A4—Paclitaxel—lung cancer	0.0206	0.0372	CbGbCtD
Palonosetron—CYP3A4—Irinotecan—lung cancer	0.0203	0.0367	CbGbCtD
Palonosetron—CYP3A4—Vinblastine—lung cancer	0.0181	0.0326	CbGbCtD
Palonosetron—CYP2D6—Doxorubicin—lung cancer	0.0175	0.0315	CbGbCtD
Palonosetron—CYP3A4—Etoposide—lung cancer	0.0163	0.0294	CbGbCtD
Palonosetron—CYP3A4—Docetaxel—lung cancer	0.0149	0.0269	CbGbCtD
Palonosetron—CYP3A4—Doxorubicin—lung cancer	0.0111	0.02	CbGbCtD
Palonosetron—Dyspnoea—Cisplatin—lung cancer	0.000195	0.000545	CcSEcCtD
Palonosetron—Skin disorder—Etoposide—lung cancer	0.000195	0.000544	CcSEcCtD
Palonosetron—Shock—Paclitaxel—lung cancer	0.000194	0.00054	CcSEcCtD
Palonosetron—Dizziness—Vinorelbine—lung cancer	0.000194	0.00054	CcSEcCtD
Palonosetron—Abdominal pain upper—Doxorubicin—lung cancer	0.000194	0.00054	CcSEcCtD
Palonosetron—Nervous system disorder—Paclitaxel—lung cancer	0.000193	0.000538	CcSEcCtD
Palonosetron—Hypokalaemia—Doxorubicin—lung cancer	0.000193	0.000538	CcSEcCtD
Palonosetron—Tachycardia—Paclitaxel—lung cancer	0.000192	0.000536	CcSEcCtD
Palonosetron—Anorexia—Etoposide—lung cancer	0.000191	0.000534	CcSEcCtD
Palonosetron—Skin disorder—Paclitaxel—lung cancer	0.000191	0.000533	CcSEcCtD
Palonosetron—Abdominal pain—Irinotecan—lung cancer	0.000191	0.000532	CcSEcCtD
Palonosetron—Body temperature increased—Irinotecan—lung cancer	0.000191	0.000532	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000191	0.000532	CcSEcCtD
Palonosetron—Decreased appetite—Cisplatin—lung cancer	0.000191	0.000531	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Cisplatin—lung cancer	0.000189	0.000528	CcSEcCtD
Palonosetron—Anaemia—Docetaxel—lung cancer	0.000189	0.000527	CcSEcCtD
Palonosetron—Anorexia—Paclitaxel—lung cancer	0.000188	0.000523	CcSEcCtD
Palonosetron—Hypotension—Etoposide—lung cancer	0.000188	0.000523	CcSEcCtD
Palonosetron—Gastritis—Doxorubicin—lung cancer	0.000188	0.000523	CcSEcCtD
Palonosetron—Pain—Cisplatin—lung cancer	0.000188	0.000523	CcSEcCtD
Palonosetron—Vomiting—Vinorelbine—lung cancer	0.000186	0.000519	CcSEcCtD
Palonosetron—Body temperature increased—Gemcitabine—lung cancer	0.000186	0.000518	CcSEcCtD
Palonosetron—Rash—Vinorelbine—lung cancer	0.000185	0.000515	CcSEcCtD
Palonosetron—Dermatitis—Vinorelbine—lung cancer	0.000184	0.000514	CcSEcCtD
Palonosetron—Abdominal distension—Doxorubicin—lung cancer	0.000184	0.000514	CcSEcCtD
Palonosetron—Hypotension—Paclitaxel—lung cancer	0.000184	0.000513	CcSEcCtD
Palonosetron—Headache—Vinorelbine—lung cancer	0.000183	0.000511	CcSEcCtD
Palonosetron—Paraesthesia—Etoposide—lung cancer	0.00018	0.000503	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000179	0.0005	CcSEcCtD
Palonosetron—Dyspnoea—Etoposide—lung cancer	0.000179	0.000499	CcSEcCtD
Palonosetron—Somnolence—Etoposide—lung cancer	0.000179	0.000498	CcSEcCtD
Palonosetron—Hepatobiliary disease—Methotrexate—lung cancer	0.000178	0.000497	CcSEcCtD
Palonosetron—Insomnia—Paclitaxel—lung cancer	0.000178	0.000497	CcSEcCtD
Palonosetron—Epistaxis—Methotrexate—lung cancer	0.000178	0.000496	CcSEcCtD
Palonosetron—Hypersensitivity—Irinotecan—lung cancer	0.000178	0.000496	CcSEcCtD
Palonosetron—Convulsion—Docetaxel—lung cancer	0.000177	0.000494	CcSEcCtD
Palonosetron—Paraesthesia—Paclitaxel—lung cancer	0.000177	0.000493	CcSEcCtD
Palonosetron—Hypertension—Docetaxel—lung cancer	0.000177	0.000492	CcSEcCtD
Palonosetron—Dyspnoea—Paclitaxel—lung cancer	0.000176	0.000489	CcSEcCtD
Palonosetron—Somnolence—Paclitaxel—lung cancer	0.000175	0.000488	CcSEcCtD
Palonosetron—Decreased appetite—Etoposide—lung cancer	0.000175	0.000487	CcSEcCtD
Palonosetron—Myalgia—Docetaxel—lung cancer	0.000174	0.000485	CcSEcCtD
Palonosetron—Arthralgia—Docetaxel—lung cancer	0.000174	0.000485	CcSEcCtD
Palonosetron—Nausea—Vinorelbine—lung cancer	0.000174	0.000485	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Etoposide—lung cancer	0.000173	0.000483	CcSEcCtD
Palonosetron—Dyspepsia—Paclitaxel—lung cancer	0.000173	0.000483	CcSEcCtD
Palonosetron—Body temperature increased—Cisplatin—lung cancer	0.000173	0.000483	CcSEcCtD
Palonosetron—Asthenia—Irinotecan—lung cancer	0.000173	0.000483	CcSEcCtD
Palonosetron—Fatigue—Etoposide—lung cancer	0.000173	0.000483	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000173	0.000482	CcSEcCtD
Palonosetron—Pain—Etoposide—lung cancer	0.000172	0.000479	CcSEcCtD
Palonosetron—Constipation—Etoposide—lung cancer	0.000172	0.000479	CcSEcCtD
Palonosetron—Decreased appetite—Paclitaxel—lung cancer	0.000171	0.000477	CcSEcCtD
Palonosetron—Dry mouth—Docetaxel—lung cancer	0.00017	0.000475	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00017	0.000474	CcSEcCtD
Palonosetron—Fatigue—Paclitaxel—lung cancer	0.00017	0.000473	CcSEcCtD
Palonosetron—Asthenia—Gemcitabine—lung cancer	0.000169	0.00047	CcSEcCtD
Palonosetron—Pain—Paclitaxel—lung cancer	0.000168	0.00047	CcSEcCtD
Palonosetron—Constipation—Paclitaxel—lung cancer	0.000168	0.00047	CcSEcCtD
Palonosetron—Urinary tract disorder—Methotrexate—lung cancer	0.000167	0.000466	CcSEcCtD
Palonosetron—Anaphylactic shock—Docetaxel—lung cancer	0.000167	0.000465	CcSEcCtD
Palonosetron—Pruritus—Gemcitabine—lung cancer	0.000166	0.000464	CcSEcCtD
Palonosetron—Urethral disorder—Methotrexate—lung cancer	0.000166	0.000463	CcSEcCtD
Palonosetron—Infection—Docetaxel—lung cancer	0.000166	0.000462	CcSEcCtD
Palonosetron—Hyperglycaemia—Doxorubicin—lung cancer	0.000165	0.000461	CcSEcCtD
Palonosetron—Diarrhoea—Irinotecan—lung cancer	0.000165	0.000461	CcSEcCtD
Palonosetron—Gastrointestinal pain—Etoposide—lung cancer	0.000164	0.000458	CcSEcCtD
Palonosetron—Shock—Docetaxel—lung cancer	0.000164	0.000458	CcSEcCtD
Palonosetron—Nervous system disorder—Docetaxel—lung cancer	0.000164	0.000456	CcSEcCtD
Palonosetron—Tachycardia—Docetaxel—lung cancer	0.000163	0.000454	CcSEcCtD
Palonosetron—Skin disorder—Docetaxel—lung cancer	0.000162	0.000452	CcSEcCtD
Palonosetron—Hypersensitivity—Cisplatin—lung cancer	0.000162	0.00045	CcSEcCtD
Palonosetron—Gastrointestinal pain—Paclitaxel—lung cancer	0.000161	0.000449	CcSEcCtD
Palonosetron—Diarrhoea—Gemcitabine—lung cancer	0.000161	0.000449	CcSEcCtD
Palonosetron—Dizziness—Irinotecan—lung cancer	0.00016	0.000445	CcSEcCtD
Palonosetron—Anorexia—Docetaxel—lung cancer	0.000159	0.000444	CcSEcCtD
Palonosetron—Abdominal pain—Etoposide—lung cancer	0.000159	0.000443	CcSEcCtD
Palonosetron—Body temperature increased—Etoposide—lung cancer	0.000159	0.000443	CcSEcCtD
Palonosetron—Eye disorder—Methotrexate—lung cancer	0.000158	0.000441	CcSEcCtD
Palonosetron—Tinnitus—Methotrexate—lung cancer	0.000158	0.00044	CcSEcCtD
Palonosetron—Asthenia—Cisplatin—lung cancer	0.000157	0.000439	CcSEcCtD
Palonosetron—Cardiac disorder—Methotrexate—lung cancer	0.000157	0.000438	CcSEcCtD
Palonosetron—Hypotension—Docetaxel—lung cancer	0.000156	0.000435	CcSEcCtD
Palonosetron—Abdominal pain—Paclitaxel—lung cancer	0.000156	0.000434	CcSEcCtD
Palonosetron—Body temperature increased—Paclitaxel—lung cancer	0.000156	0.000434	CcSEcCtD
Palonosetron—Hepatobiliary disease—Doxorubicin—lung cancer	0.000155	0.000431	CcSEcCtD
Palonosetron—Epistaxis—Doxorubicin—lung cancer	0.000154	0.00043	CcSEcCtD
Palonosetron—Angiopathy—Methotrexate—lung cancer	0.000154	0.000428	CcSEcCtD
Palonosetron—Vomiting—Irinotecan—lung cancer	0.000154	0.000428	CcSEcCtD
Palonosetron—Sinusitis—Doxorubicin—lung cancer	0.000153	0.000427	CcSEcCtD
Palonosetron—Immune system disorder—Methotrexate—lung cancer	0.000153	0.000426	CcSEcCtD
Palonosetron—Mediastinal disorder—Methotrexate—lung cancer	0.000153	0.000425	CcSEcCtD
Palonosetron—Rash—Irinotecan—lung cancer	0.000152	0.000424	CcSEcCtD
Palonosetron—Dermatitis—Irinotecan—lung cancer	0.000152	0.000424	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000152	0.000424	CcSEcCtD
Palonosetron—Chills—Methotrexate—lung cancer	0.000152	0.000424	CcSEcCtD
Palonosetron—Headache—Irinotecan—lung cancer	0.000151	0.000422	CcSEcCtD
Palonosetron—Insomnia—Docetaxel—lung cancer	0.000151	0.000421	CcSEcCtD
Palonosetron—Diarrhoea—Cisplatin—lung cancer	0.00015	0.000418	CcSEcCtD
Palonosetron—Paraesthesia—Docetaxel—lung cancer	0.00015	0.000418	CcSEcCtD
Palonosetron—Alopecia—Methotrexate—lung cancer	0.00015	0.000417	CcSEcCtD
Palonosetron—Vomiting—Gemcitabine—lung cancer	0.00015	0.000417	CcSEcCtD
Palonosetron—Bradycardia—Doxorubicin—lung cancer	0.000149	0.000416	CcSEcCtD
Palonosetron—Dyspnoea—Docetaxel—lung cancer	0.000149	0.000415	CcSEcCtD
Palonosetron—Somnolence—Docetaxel—lung cancer	0.000148	0.000414	CcSEcCtD
Palonosetron—Mental disorder—Methotrexate—lung cancer	0.000148	0.000414	CcSEcCtD
Palonosetron—Rash—Gemcitabine—lung cancer	0.000148	0.000413	CcSEcCtD
Palonosetron—Dermatitis—Gemcitabine—lung cancer	0.000148	0.000413	CcSEcCtD
Palonosetron—Hypersensitivity—Etoposide—lung cancer	0.000148	0.000413	CcSEcCtD
Palonosetron—Malnutrition—Methotrexate—lung cancer	0.000147	0.000411	CcSEcCtD
Palonosetron—Erythema—Methotrexate—lung cancer	0.000147	0.000411	CcSEcCtD
Palonosetron—Headache—Gemcitabine—lung cancer	0.000147	0.000411	CcSEcCtD
Palonosetron—Dyspepsia—Docetaxel—lung cancer	0.000147	0.00041	CcSEcCtD
Palonosetron—Decreased appetite—Docetaxel—lung cancer	0.000145	0.000405	CcSEcCtD
Palonosetron—Hypersensitivity—Paclitaxel—lung cancer	0.000145	0.000405	CcSEcCtD
Palonosetron—Urinary tract disorder—Doxorubicin—lung cancer	0.000145	0.000404	CcSEcCtD
Palonosetron—Dysgeusia—Methotrexate—lung cancer	0.000144	0.000402	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Docetaxel—lung cancer	0.000144	0.000402	CcSEcCtD
Palonosetron—Asthenia—Etoposide—lung cancer	0.000144	0.000402	CcSEcCtD
Palonosetron—Connective tissue disorder—Doxorubicin—lung cancer	0.000144	0.000402	CcSEcCtD
Palonosetron—Fatigue—Docetaxel—lung cancer	0.000144	0.000401	CcSEcCtD
Palonosetron—Urethral disorder—Doxorubicin—lung cancer	0.000144	0.000401	CcSEcCtD
Palonosetron—Nausea—Irinotecan—lung cancer	0.000143	0.0004	CcSEcCtD
Palonosetron—Pain—Docetaxel—lung cancer	0.000143	0.000398	CcSEcCtD
Palonosetron—Constipation—Docetaxel—lung cancer	0.000143	0.000398	CcSEcCtD
Palonosetron—Pruritus—Etoposide—lung cancer	0.000142	0.000396	CcSEcCtD
Palonosetron—Asthenia—Paclitaxel—lung cancer	0.000141	0.000394	CcSEcCtD
Palonosetron—Nausea—Gemcitabine—lung cancer	0.00014	0.00039	CcSEcCtD
Palonosetron—Vomiting—Cisplatin—lung cancer	0.000139	0.000389	CcSEcCtD
Palonosetron—Pruritus—Paclitaxel—lung cancer	0.000139	0.000388	CcSEcCtD
Palonosetron—Rash—Cisplatin—lung cancer	0.000138	0.000385	CcSEcCtD
Palonosetron—Dermatitis—Cisplatin—lung cancer	0.000138	0.000385	CcSEcCtD
Palonosetron—Diarrhoea—Etoposide—lung cancer	0.000137	0.000383	CcSEcCtD
Palonosetron—Eye disorder—Doxorubicin—lung cancer	0.000137	0.000382	CcSEcCtD
Palonosetron—Tinnitus—Doxorubicin—lung cancer	0.000137	0.000381	CcSEcCtD
Palonosetron—Gastrointestinal pain—Docetaxel—lung cancer	0.000137	0.000381	CcSEcCtD
Palonosetron—Anaemia—Methotrexate—lung cancer	0.000136	0.00038	CcSEcCtD
Palonosetron—Cardiac disorder—Doxorubicin—lung cancer	0.000136	0.000379	CcSEcCtD
Palonosetron—Diarrhoea—Paclitaxel—lung cancer	0.000135	0.000376	CcSEcCtD
Palonosetron—Angiopathy—Doxorubicin—lung cancer	0.000133	0.000371	CcSEcCtD
Palonosetron—Dizziness—Etoposide—lung cancer	0.000133	0.00037	CcSEcCtD
Palonosetron—Immune system disorder—Doxorubicin—lung cancer	0.000132	0.000369	CcSEcCtD
Palonosetron—Mediastinal disorder—Doxorubicin—lung cancer	0.000132	0.000368	CcSEcCtD
Palonosetron—Abdominal pain—Docetaxel—lung cancer	0.000132	0.000368	CcSEcCtD
Palonosetron—Body temperature increased—Docetaxel—lung cancer	0.000132	0.000368	CcSEcCtD
Palonosetron—Chills—Doxorubicin—lung cancer	0.000132	0.000367	CcSEcCtD
Palonosetron—Arrhythmia—Doxorubicin—lung cancer	0.000131	0.000365	CcSEcCtD
Palonosetron—Dizziness—Paclitaxel—lung cancer	0.00013	0.000363	CcSEcCtD
Palonosetron—Nausea—Cisplatin—lung cancer	0.00013	0.000363	CcSEcCtD
Palonosetron—Alopecia—Doxorubicin—lung cancer	0.00013	0.000361	CcSEcCtD
Palonosetron—Mental disorder—Doxorubicin—lung cancer	0.000128	0.000358	CcSEcCtD
Palonosetron—Convulsion—Methotrexate—lung cancer	0.000128	0.000356	CcSEcCtD
Palonosetron—Vomiting—Etoposide—lung cancer	0.000128	0.000356	CcSEcCtD
Palonosetron—Erythema—Doxorubicin—lung cancer	0.000128	0.000356	CcSEcCtD
Palonosetron—Malnutrition—Doxorubicin—lung cancer	0.000128	0.000356	CcSEcCtD
Palonosetron—Rash—Etoposide—lung cancer	0.000127	0.000353	CcSEcCtD
Palonosetron—Dermatitis—Etoposide—lung cancer	0.000127	0.000353	CcSEcCtD
Palonosetron—Headache—Etoposide—lung cancer	0.000126	0.000351	CcSEcCtD
Palonosetron—Flatulence—Doxorubicin—lung cancer	0.000126	0.000351	CcSEcCtD
Palonosetron—Myalgia—Methotrexate—lung cancer	0.000126	0.00035	CcSEcCtD
Palonosetron—Arthralgia—Methotrexate—lung cancer	0.000126	0.00035	CcSEcCtD
Palonosetron—Vomiting—Paclitaxel—lung cancer	0.000125	0.000349	CcSEcCtD
Palonosetron—Dysgeusia—Doxorubicin—lung cancer	0.000125	0.000348	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000125	0.000347	CcSEcCtD
Palonosetron—Rash—Paclitaxel—lung cancer	0.000124	0.000346	CcSEcCtD
Palonosetron—Dermatitis—Paclitaxel—lung cancer	0.000124	0.000346	CcSEcCtD
Palonosetron—Discomfort—Methotrexate—lung cancer	0.000124	0.000346	CcSEcCtD
Palonosetron—Headache—Paclitaxel—lung cancer	0.000123	0.000344	CcSEcCtD
Palonosetron—Hypersensitivity—Docetaxel—lung cancer	0.000123	0.000343	CcSEcCtD
Palonosetron—Anaphylactic shock—Methotrexate—lung cancer	0.00012	0.000335	CcSEcCtD
Palonosetron—Asthenia—Docetaxel—lung cancer	0.00012	0.000334	CcSEcCtD
Palonosetron—Infection—Methotrexate—lung cancer	0.00012	0.000333	CcSEcCtD
Palonosetron—Nausea—Etoposide—lung cancer	0.000119	0.000333	CcSEcCtD
Palonosetron—Pruritus—Docetaxel—lung cancer	0.000118	0.000329	CcSEcCtD
Palonosetron—Nervous system disorder—Methotrexate—lung cancer	0.000118	0.000329	CcSEcCtD
Palonosetron—Anaemia—Doxorubicin—lung cancer	0.000118	0.000329	CcSEcCtD
Palonosetron—Nausea—Paclitaxel—lung cancer	0.000117	0.000326	CcSEcCtD
Palonosetron—Skin disorder—Methotrexate—lung cancer	0.000117	0.000326	CcSEcCtD
Palonosetron—Anorexia—Methotrexate—lung cancer	0.000115	0.00032	CcSEcCtD
Palonosetron—Diarrhoea—Docetaxel—lung cancer	0.000114	0.000318	CcSEcCtD
Palonosetron—Hypotension—Methotrexate—lung cancer	0.000112	0.000313	CcSEcCtD
Palonosetron—Convulsion—Doxorubicin—lung cancer	0.000111	0.000308	CcSEcCtD
Palonosetron—Dizziness—Docetaxel—lung cancer	0.00011	0.000308	CcSEcCtD
Palonosetron—Hypertension—Doxorubicin—lung cancer	0.00011	0.000307	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00011	0.000306	CcSEcCtD
Palonosetron—Insomnia—Methotrexate—lung cancer	0.000109	0.000303	CcSEcCtD
Palonosetron—Myalgia—Doxorubicin—lung cancer	0.000109	0.000303	CcSEcCtD
Palonosetron—Arthralgia—Doxorubicin—lung cancer	0.000109	0.000303	CcSEcCtD
Palonosetron—Anxiety—Doxorubicin—lung cancer	0.000108	0.000302	CcSEcCtD
Palonosetron—Paraesthesia—Methotrexate—lung cancer	0.000108	0.000301	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000108	0.000301	CcSEcCtD
Palonosetron—Discomfort—Doxorubicin—lung cancer	0.000107	0.000299	CcSEcCtD
Palonosetron—Dyspnoea—Methotrexate—lung cancer	0.000107	0.000299	CcSEcCtD
Palonosetron—Somnolence—Methotrexate—lung cancer	0.000107	0.000298	CcSEcCtD
Palonosetron—Dry mouth—Doxorubicin—lung cancer	0.000106	0.000296	CcSEcCtD
Palonosetron—Vomiting—Docetaxel—lung cancer	0.000106	0.000296	CcSEcCtD
Palonosetron—Dyspepsia—Methotrexate—lung cancer	0.000106	0.000295	CcSEcCtD
Palonosetron—Rash—Docetaxel—lung cancer	0.000105	0.000293	CcSEcCtD
Palonosetron—Dermatitis—Docetaxel—lung cancer	0.000105	0.000293	CcSEcCtD
Palonosetron—Decreased appetite—Methotrexate—lung cancer	0.000105	0.000292	CcSEcCtD
Palonosetron—Headache—Docetaxel—lung cancer	0.000105	0.000292	CcSEcCtD
Palonosetron—Anaphylactic shock—Doxorubicin—lung cancer	0.000104	0.00029	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Methotrexate—lung cancer	0.000104	0.00029	CcSEcCtD
Palonosetron—Fatigue—Methotrexate—lung cancer	0.000104	0.000289	CcSEcCtD
Palonosetron—Infection—Doxorubicin—lung cancer	0.000104	0.000289	CcSEcCtD
Palonosetron—Pain—Methotrexate—lung cancer	0.000103	0.000287	CcSEcCtD
Palonosetron—Shock—Doxorubicin—lung cancer	0.000103	0.000286	CcSEcCtD
Palonosetron—Nervous system disorder—Doxorubicin—lung cancer	0.000102	0.000285	CcSEcCtD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000102	0.00117	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000102	0.00117	CbGpPWpGaD
Palonosetron—Tachycardia—Doxorubicin—lung cancer	0.000102	0.000283	CcSEcCtD
Palonosetron—Skin disorder—Doxorubicin—lung cancer	0.000101	0.000282	CcSEcCtD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	0.000101	0.00116	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—HPGDS—lung cancer	0.000101	0.00115	CbGpPWpGaD
Palonosetron—Anorexia—Doxorubicin—lung cancer	9.93e-05	0.000277	CcSEcCtD
Palonosetron—Nausea—Docetaxel—lung cancer	9.92e-05	0.000276	CcSEcCtD
Palonosetron—Gastrointestinal pain—Methotrexate—lung cancer	9.84e-05	0.000274	CcSEcCtD
Palonosetron—CYP3A4—Biological oxidations—GSTA1—lung cancer	9.82e-05	0.00113	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—APOA1—lung cancer	9.79e-05	0.00112	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	9.76e-05	0.00112	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GSTT1—lung cancer	9.76e-05	0.00112	CbGpPWpGaD
Palonosetron—Hypotension—Doxorubicin—lung cancer	9.74e-05	0.000271	CcSEcCtD
Palonosetron—CYP2D6—Biological oxidations—CYP2E1—lung cancer	9.68e-05	0.00111	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2A6—lung cancer	9.65e-05	0.00111	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GCLC—lung cancer	9.65e-05	0.00111	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	9.55e-05	0.0011	CbGpPWpGaD
Palonosetron—Body temperature increased—Methotrexate—lung cancer	9.51e-05	0.000265	CcSEcCtD
Palonosetron—Abdominal pain—Methotrexate—lung cancer	9.51e-05	0.000265	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.49e-05	0.000265	CcSEcCtD
Palonosetron—Insomnia—Doxorubicin—lung cancer	9.42e-05	0.000263	CcSEcCtD
Palonosetron—CYP1A2—Arachidonic acid metabolism—PTGS2—lung cancer	9.42e-05	0.00108	CbGpPWpGaD
Palonosetron—Paraesthesia—Doxorubicin—lung cancer	9.36e-05	0.000261	CcSEcCtD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	9.33e-05	0.00107	CbGpPWpGaD
Palonosetron—Dyspnoea—Doxorubicin—lung cancer	9.29e-05	0.000259	CcSEcCtD
Palonosetron—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	9.28e-05	0.00106	CbGpPWpGaD
Palonosetron—Somnolence—Doxorubicin—lung cancer	9.26e-05	0.000258	CcSEcCtD
Palonosetron—Dyspepsia—Doxorubicin—lung cancer	9.17e-05	0.000256	CcSEcCtD
Palonosetron—CYP3A4—Biological oxidations—UGT1A1—lung cancer	9.13e-05	0.00105	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	9.08e-05	0.00104	CbGpPWpGaD
Palonosetron—Decreased appetite—Doxorubicin—lung cancer	9.06e-05	0.000252	CcSEcCtD
Palonosetron—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	9.01e-05	0.00103	CbGpPWpGaD
Palonosetron—Gastrointestinal disorder—Doxorubicin—lung cancer	9e-05	0.000251	CcSEcCtD
Palonosetron—Fatigue—Doxorubicin—lung cancer	8.98e-05	0.00025	CcSEcCtD
Palonosetron—Constipation—Doxorubicin—lung cancer	8.91e-05	0.000248	CcSEcCtD
Palonosetron—Pain—Doxorubicin—lung cancer	8.91e-05	0.000248	CcSEcCtD
Palonosetron—Hypersensitivity—Methotrexate—lung cancer	8.87e-05	0.000247	CcSEcCtD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	8.82e-05	0.00101	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	8.8e-05	0.00101	CbGpPWpGaD
Palonosetron—Asthenia—Methotrexate—lung cancer	8.63e-05	0.000241	CcSEcCtD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	8.56e-05	0.000983	CbGpPWpGaD
Palonosetron—Gastrointestinal pain—Doxorubicin—lung cancer	8.52e-05	0.000237	CcSEcCtD
Palonosetron—Pruritus—Methotrexate—lung cancer	8.51e-05	0.000237	CcSEcCtD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—EP300—lung cancer	8.37e-05	0.000961	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	8.37e-05	0.000961	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—CREBBP—lung cancer	8.28e-05	0.000951	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—POMC—lung cancer	8.27e-05	0.000949	CbGpPWpGaD
Palonosetron—Body temperature increased—Doxorubicin—lung cancer	8.24e-05	0.00023	CcSEcCtD
Palonosetron—Abdominal pain—Doxorubicin—lung cancer	8.24e-05	0.00023	CcSEcCtD
Palonosetron—Diarrhoea—Methotrexate—lung cancer	8.23e-05	0.000229	CcSEcCtD
Palonosetron—CYP1A2—Biological oxidations—CYP2E1—lung cancer	8.2e-05	0.000941	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	8.14e-05	0.000934	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	8.14e-05	0.000934	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	8.09e-05	0.000928	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	8.06e-05	0.000925	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—GSTP1—lung cancer	7.99e-05	0.000916	CbGpPWpGaD
Palonosetron—Dizziness—Methotrexate—lung cancer	7.96e-05	0.000222	CcSEcCtD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	7.93e-05	0.00091	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	7.88e-05	0.000904	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.87e-05	0.000904	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	7.83e-05	0.000899	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—HPGDS—lung cancer	7.77e-05	0.000891	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ALB—lung cancer	7.75e-05	0.00089	CbGpPWpGaD
Palonosetron—Hypersensitivity—Doxorubicin—lung cancer	7.68e-05	0.000214	CcSEcCtD
Palonosetron—Vomiting—Methotrexate—lung cancer	7.65e-05	0.000213	CcSEcCtD
Palonosetron—Rash—Methotrexate—lung cancer	7.59e-05	0.000211	CcSEcCtD
Palonosetron—Dermatitis—Methotrexate—lung cancer	7.58e-05	0.000211	CcSEcCtD
Palonosetron—Headache—Methotrexate—lung cancer	7.54e-05	0.00021	CcSEcCtD
Palonosetron—CYP3A4—Biological oxidations—GSTT1—lung cancer	7.53e-05	0.000864	CbGpPWpGaD
Palonosetron—Asthenia—Doxorubicin—lung cancer	7.48e-05	0.000208	CcSEcCtD
Palonosetron—CYP3A4—Biological oxidations—GCLC—lung cancer	7.45e-05	0.000854	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2A6—lung cancer	7.45e-05	0.000854	CbGpPWpGaD
Palonosetron—Pruritus—Doxorubicin—lung cancer	7.37e-05	0.000205	CcSEcCtD
Palonosetron—CYP2D6—Biological oxidations—GSTM1—lung cancer	7.34e-05	0.000842	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	7.3e-05	0.000837	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	7.24e-05	0.000831	CbGpPWpGaD
Palonosetron—Nausea—Methotrexate—lung cancer	7.15e-05	0.000199	CcSEcCtD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	7.14e-05	0.000819	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	7.14e-05	0.000819	CbGpPWpGaD
Palonosetron—Diarrhoea—Doxorubicin—lung cancer	7.13e-05	0.000199	CcSEcCtD
Palonosetron—HTR3A—Transmembrane transport of small molecules—RAF1—lung cancer	7.01e-05	0.000805	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP1A1—lung cancer	6.96e-05	0.000798	CbGpPWpGaD
Palonosetron—Dizziness—Doxorubicin—lung cancer	6.89e-05	0.000192	CcSEcCtD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	6.86e-05	0.000787	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	6.86e-05	0.000787	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GSTP1—lung cancer	6.76e-05	0.000776	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	6.74e-05	0.000774	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	6.67e-05	0.000766	CbGpPWpGaD
Palonosetron—Vomiting—Doxorubicin—lung cancer	6.62e-05	0.000185	CcSEcCtD
Palonosetron—Rash—Doxorubicin—lung cancer	6.57e-05	0.000183	CcSEcCtD
Palonosetron—Dermatitis—Doxorubicin—lung cancer	6.56e-05	0.000183	CcSEcCtD
Palonosetron—Headache—Doxorubicin—lung cancer	6.53e-05	0.000182	CcSEcCtD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	6.38e-05	0.000733	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2E1—lung cancer	6.33e-05	0.000727	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	6.24e-05	0.000717	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GSTM1—lung cancer	6.22e-05	0.000713	CbGpPWpGaD
Palonosetron—Nausea—Doxorubicin—lung cancer	6.19e-05	0.000173	CcSEcCtD
Palonosetron—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	6.13e-05	0.000704	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—COL4A3BP—lung cancer	6.12e-05	0.000702	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AZIN2—lung cancer	6.12e-05	0.000702	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP1A1—lung cancer	5.89e-05	0.000676	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	5.81e-05	0.000667	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	5.73e-05	0.000658	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GSTP1—lung cancer	5.22e-05	0.000599	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ATP5H—lung cancer	5.2e-05	0.000597	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—POMC—lung cancer	5.19e-05	0.000595	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AZIN2—lung cancer	5.18e-05	0.000595	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—COL4A3BP—lung cancer	5.18e-05	0.000595	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	5.15e-05	0.000591	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.83e-05	0.000555	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.8e-05	0.000551	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.73e-05	0.000543	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.68e-05	0.000537	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PLBD1—lung cancer	4.64e-05	0.000532	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.55e-05	0.000522	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.49e-05	0.000515	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ATP5H—lung cancer	4.41e-05	0.000506	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—POMC—lung cancer	4.39e-05	0.000504	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HSD17B10—lung cancer	4.24e-05	0.000487	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.05e-05	0.000465	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—COL4A3BP—lung cancer	4e-05	0.000459	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AZIN2—lung cancer	4e-05	0.000459	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CKB—lung cancer	3.94e-05	0.000453	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PLBD1—lung cancer	3.93e-05	0.000451	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.86e-05	0.000443	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTM2—lung cancer	3.71e-05	0.000425	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CNDP2—lung cancer	3.71e-05	0.000425	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MTMR3—lung cancer	3.61e-05	0.000414	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HSD17B10—lung cancer	3.59e-05	0.000412	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PGAM1—lung cancer	3.51e-05	0.000403	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ATP5H—lung cancer	3.4e-05	0.00039	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—POMC—lung cancer	3.39e-05	0.000389	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2A7—lung cancer	3.35e-05	0.000385	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CKB—lung cancer	3.34e-05	0.000383	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SDC4—lung cancer	3.28e-05	0.000377	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTM2—lung cancer	3.14e-05	0.00036	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CNDP2—lung cancer	3.14e-05	0.00036	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MTMR3—lung cancer	3.06e-05	0.000351	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PLBD1—lung cancer	3.03e-05	0.000348	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTA3—lung cancer	2.99e-05	0.000343	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—RRM1—lung cancer	2.99e-05	0.000343	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PGAM1—lung cancer	2.98e-05	0.000342	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2A7—lung cancer	2.84e-05	0.000326	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—B4GALT5—lung cancer	2.81e-05	0.000322	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SDC4—lung cancer	2.78e-05	0.000319	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HSD17B10—lung cancer	2.77e-05	0.000318	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTA4—lung cancer	2.73e-05	0.000314	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTA2—lung cancer	2.66e-05	0.000306	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CKB—lung cancer	2.58e-05	0.000296	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTA1—lung cancer	2.57e-05	0.000295	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCC3—lung cancer	2.54e-05	0.000292	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—RRM1—lung cancer	2.53e-05	0.000291	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTA3—lung cancer	2.53e-05	0.000291	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKR1C1—lung cancer	2.46e-05	0.000282	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CNDP2—lung cancer	2.42e-05	0.000278	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTM2—lung cancer	2.42e-05	0.000278	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—UGT1A1—lung cancer	2.39e-05	0.000274	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—B4GALT5—lung cancer	2.38e-05	0.000273	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MTMR3—lung cancer	2.36e-05	0.000271	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTA4—lung cancer	2.32e-05	0.000266	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GNG11—lung cancer	2.3e-05	0.000264	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PGAM1—lung cancer	2.3e-05	0.000264	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.26e-05	0.00026	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTA2—lung cancer	2.26e-05	0.000259	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALDOA—lung cancer	2.19e-05	0.000252	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2A7—lung cancer	2.19e-05	0.000252	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTA1—lung cancer	2.18e-05	0.00025	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCC3—lung cancer	2.15e-05	0.000247	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SDC4—lung cancer	2.15e-05	0.000246	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NCOA3—lung cancer	2.13e-05	0.000244	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKR1C1—lung cancer	2.08e-05	0.000239	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADCY1—lung cancer	2.07e-05	0.000238	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCG2—lung cancer	2.07e-05	0.000238	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ENO2—lung cancer	2.03e-05	0.000233	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HPGDS—lung cancer	2.03e-05	0.000233	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—UGT1A1—lung cancer	2.02e-05	0.000232	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.02e-05	0.000232	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTT1—lung cancer	1.97e-05	0.000226	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—RRM1—lung cancer	1.95e-05	0.000224	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTA3—lung cancer	1.95e-05	0.000224	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GNG11—lung cancer	1.95e-05	0.000224	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GCLC—lung cancer	1.95e-05	0.000224	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2A6—lung cancer	1.95e-05	0.000224	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.94e-05	0.000223	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALDOA—lung cancer	1.86e-05	0.000213	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ENO1—lung cancer	1.85e-05	0.000212	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—B4GALT5—lung cancer	1.84e-05	0.000211	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NCOA3—lung cancer	1.8e-05	0.000207	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTA4—lung cancer	1.79e-05	0.000205	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.77e-05	0.000203	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCG2—lung cancer	1.75e-05	0.000201	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADCY1—lung cancer	1.75e-05	0.000201	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTA2—lung cancer	1.74e-05	0.0002	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ENO2—lung cancer	1.72e-05	0.000197	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HPGDS—lung cancer	1.72e-05	0.000197	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.71e-05	0.000196	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.69e-05	0.000194	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTA1—lung cancer	1.68e-05	0.000193	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTT1—lung cancer	1.67e-05	0.000192	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCC3—lung cancer	1.66e-05	0.000191	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2E1—lung cancer	1.66e-05	0.00019	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GCLC—lung cancer	1.65e-05	0.000189	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2A6—lung cancer	1.65e-05	0.000189	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.64e-05	0.000189	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NQO1—lung cancer	1.64e-05	0.000188	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKR1C1—lung cancer	1.61e-05	0.000185	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ENO1—lung cancer	1.56e-05	0.000179	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—UGT1A1—lung cancer	1.56e-05	0.000179	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.56e-05	0.000179	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.54e-05	0.000177	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GNG11—lung cancer	1.51e-05	0.000173	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—STK11—lung cancer	1.48e-05	0.000169	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALDOA—lung cancer	1.43e-05	0.000165	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2E1—lung cancer	1.4e-05	0.000161	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NCOA3—lung cancer	1.39e-05	0.00016	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NQO1—lung cancer	1.39e-05	0.000159	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTP1—lung cancer	1.37e-05	0.000157	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.36e-05	0.000156	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADCY1—lung cancer	1.35e-05	0.000155	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCG2—lung cancer	1.35e-05	0.000155	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.35e-05	0.000154	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CAT—lung cancer	1.33e-05	0.000153	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ENO2—lung cancer	1.33e-05	0.000152	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HPGDS—lung cancer	1.33e-05	0.000152	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.32e-05	0.000151	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCB1—lung cancer	1.29e-05	0.000148	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTT1—lung cancer	1.29e-05	0.000148	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2A6—lung cancer	1.27e-05	0.000146	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GCLC—lung cancer	1.27e-05	0.000146	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—TYMS—lung cancer	1.27e-05	0.000146	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTM1—lung cancer	1.25e-05	0.000144	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—STK11—lung cancer	1.25e-05	0.000143	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ENO1—lung cancer	1.21e-05	0.000139	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP1A1—lung cancer	1.19e-05	0.000137	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ERCC2—lung cancer	1.18e-05	0.000135	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.17e-05	0.000135	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTP1—lung cancer	1.16e-05	0.000133	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CAT—lung cancer	1.13e-05	0.000129	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.12e-05	0.000128	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCB1—lung cancer	1.1e-05	0.000126	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2E1—lung cancer	1.08e-05	0.000124	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—TYMS—lung cancer	1.08e-05	0.000123	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NQO1—lung cancer	1.07e-05	0.000123	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTM1—lung cancer	1.06e-05	0.000122	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOA1—lung cancer	1.02e-05	0.000117	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP1A1—lung cancer	1.01e-05	0.000116	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ERCC2—lung cancer	1e-05	0.000115	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—STK11—lung cancer	9.65e-06	0.000111	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CG—lung cancer	9.32e-06	0.000107	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTP1—lung cancer	8.93e-06	0.000102	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—POMC—lung cancer	8.87e-06	0.000102	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CAT—lung cancer	8.69e-06	9.97e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOA1—lung cancer	8.65e-06	9.92e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CREBBP—lung cancer	8.64e-06	9.92e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCB1—lung cancer	8.45e-06	9.7e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—TYMS—lung cancer	8.3e-06	9.53e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.28e-06	9.5e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTM1—lung cancer	8.2e-06	9.42e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CD—lung cancer	8.19e-06	9.4e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALB—lung cancer	8.09e-06	9.28e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CG—lung cancer	7.89e-06	9.06e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP1A1—lung cancer	7.78e-06	8.93e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ERCC2—lung cancer	7.71e-06	8.85e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—POMC—lung cancer	7.51e-06	8.62e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CREBBP—lung cancer	7.32e-06	8.4e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CB—lung cancer	7.14e-06	8.19e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS2—lung cancer	7.07e-06	8.12e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CD—lung cancer	6.94e-06	7.96e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALB—lung cancer	6.85e-06	7.86e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOA1—lung cancer	6.67e-06	7.66e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTEN—lung cancer	6.17e-06	7.08e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CG—lung cancer	6.09e-06	6.99e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CB—lung cancer	6.05e-06	6.94e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS2—lung cancer	5.99e-06	6.88e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—EP300—lung cancer	5.88e-06	6.75e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—POMC—lung cancer	5.8e-06	6.66e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CREBBP—lung cancer	5.65e-06	6.48e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CD—lung cancer	5.36e-06	6.15e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALB—lung cancer	5.29e-06	6.07e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTEN—lung cancer	5.23e-06	6e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—EP300—lung cancer	4.98e-06	5.72e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CB—lung cancer	4.67e-06	5.36e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS2—lung cancer	4.63e-06	5.31e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CA—lung cancer	4.35e-06	5e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTEN—lung cancer	4.03e-06	4.63e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—EP300—lung cancer	3.85e-06	4.42e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CA—lung cancer	3.69e-06	4.23e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKT1—lung cancer	3.56e-06	4.08e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKT1—lung cancer	3.01e-06	3.46e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CA—lung cancer	2.85e-06	3.27e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKT1—lung cancer	2.32e-06	2.67e-05	CbGpPWpGaD
